Summary:
A Randomized, Multicenter, Double-Blind, Placebo-Controlled, Phase 2 Study of ABP-450 (prabotulinumtoxinA) Purified Neurotoxin Complex for the Prevention of Migraine Headache.
Qualified Participants Must:
• Male or female patients 18 years or older of age (no upper age limit) at the time of signing the informed consent
• Have a minimum of 6 migraine days per month
• Have at least 1 year history of diagnosed migraines
• Subject is on a stable dose of medications
Qualified Participants May Receive:
Health Checks, Assessments & Physical Examination in relation to study no cost to you. Access to study drug while in study and compensation for qualifying participants.